CytoDyn Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Cash & Equivalents	4.98	11.9	3.11	2.54	4.23	33.94
Cash & Short-Term Investments	4.98	11.9	3.11	2.54	4.23	33.94
Cash Growth	-76.65%	282.73%	22.39%	-39.94%	-87.53%	137.66%
Other Receivables	-	2	-	-	-	-
Receivables	-	2	-	-	-	-
Prepaid Expenses	0.56	0.25	0.46	1.17	5.2	0.62
Restricted Cash	-	-	6.7	6.51	-	-
Other Current Assets	3.3	3.72	0.54	0.59	1.09	1.54
Total Current Assets	8.84	17.88	10.82	10.81	10.52	36.1
Property, Plant & Equipment	0.07	0.13	0.26	0.4	0.54	0.85
Other Intangible Assets	-	-	-	-	-	1.65
Other Long-Term Assets	0.03	0.04	0.06	0.09	18.13	93.48
Total Assets	8.94	18.05	11.14	11.29	29.19	132.08
Accounts Payable	14.25	14.69	29.56	62.73	67.97	65.9
Accrued Expenses	34.59	20.22	17.6	17.13	14.84	21.08
Current Portion of Long-Term Debt	27.2	27.2	29.79	34.42	36.24	62.75
Current Portion of Leases	0.07	0.14	0.14	0.14	0.13	0.18
Other Current Liabilities	9.01	8.27	7.09	5.39	3.98	2.65
Total Current Liabilities	85.11	70.52	84.18	119.8	123.16	152.55
Long-Term Debt	-	-	-	0.71	-	-
Long-Term Leases	-	-	0.14	0.28	0.42	0.55
Other Long-Term Liabilities	43.57	43.57	43.57	-	-	-
Total Liabilities	128.68	114.09	127.89	120.79	123.58	153.1
Common Stock	1.27	1.25	1.06	0.92	0.72	0.63
Additional Paid-In Capital	794.92	790.5	773.71	731.27	671.01	532.03
Retained Earnings	-915.93	-887.79	-891.53	-841.69	-766.13	-553.68
Total Common Equity	-119.75	-96.04	-116.76	-109.5	-94.4	-21.02
Shareholders' Equity	-119.75	-96.04	-116.76	-109.5	-94.4	-21.02
Total Liabilities & Equity	8.94	18.05	11.14	11.29	29.19	132.08
Total Debt	27.27	27.34	30.08	35.55	36.8	63.47
Net Cash (Debt)	-22.29	-15.44	-26.97	-33.01	-32.57	-29.53
Net Cash Per Share	-0.02	-0.01	-0.03	-0.04	-0.05	-0.05
Filing Date Shares Outstanding	1,270	1,251	1,214	930.52	810.28	632.14
Total Common Shares Outstanding	1,266	1,249	1,059	918.61	719.59	625.68
Working Capital	-76.27	-52.64	-73.37	-108.99	-112.65	-116.44
Book Value Per Share	-0.09	-0.08	-0.11	-0.12	-0.13	-0.03
Tangible Book Value	-119.75	-96.04	-116.76	-109.5	-94.4	-22.67
Tangible Book Value Per Share	-0.09	-0.08	-0.11	-0.12	-0.13	-0.04

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.